MARAMAI SAMUELE | Elenco docenti

Ciccone, V., Cecchin, C., Frosini, M., Saletti, M., Maramai, S., Giuliani, G., et al. (2026). VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES [10.1016/j.ejps.2025.107422]. - dettaglio
Maramai, S., Taddei, M., Castagnetti, A., Viciani, E., Koufi, F., Neri, I., et al. (2025). Drug enteric metabolism in gut microbiota-brain crosstalk. LIFE SCIENCES, 383 [10.1016/j.lfs.2025.124075]. - dettaglio
Paolino, M., Saletti, M., Venditti, J., Castriconi, F., Giuliani, G., Maramai, S., et al. (2025). Use of imidazo[1,5-a]quinoline scaffold as the pharmacophore in the design of bivalent ligands of central benzodiazepine receptors. BIOORGANIC & MEDICINAL CHEMISTRY, 117 [10.1016/j.bmc.2024.118006]. - dettaglio
Maramai, S., Mugnaini, C., Paolino, M., Schiano Moriello, A., De Petrocellis, L., Corelli, F., et al. (2025). Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists. MOLECULES, 30(3) [10.3390/molecules30030721]. - dettaglio
Poggialini, F., Governa, P., Vagaggini, C., Maramai, S., Lamponi, S., Mugnaini, C., et al. (2025). Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 209 [10.1016/j.ejps.2025.107066]. - dettaglio